ArticleAnnals of hematology2021

Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.

Anna Hinze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.